ZBH Zimmer Biomet: Forward P/S Multiple

Graphic logo of Zimmer Biomet Corp (ZBH)

Zimmer Biomet Holdings (ZBH) stability relies on sophisticated manufacturing facilities in the US and Europe with strict standards control. The forward P/S indicator visualizes market expectations, where the 1.00 level reflects the current value of the metric. Growth is supported by robotic platforms for surgeons, while the new CEO is systematically optimizing the management structure to restore margins and drive the digital transformation of the portfolio.

Zimmer Biomet - ZBH Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/17/2026)

Metric breakdowns and analytics for zimmerbiomet.com (ZBH)

- current price and projected stock value:
Summary company analytics:Zimmer Biomet Holdings, Inc. (ZBH)
Product sample of Zimmer Biomet Holdings

The forward P/S ratio assesses the market value of a business relative to expected revenue, determining the premium paid for future growth. For Zimmer Biomet Holdings (ZBH), this multiple reflects the monetization of patent protection and the long-term loyalty of surgeons to its implants. The dynamics of the forward P/S ratio allow for a comparison of market expectations against the actual pace of sales expansion, confirming the fundamental capital stability of the company.

Key competitors

Forward P/S Multiple BSX (bostonscientific.com)|EW: Market Cap to Projected Revenue|ResMed - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Corporation|COO: Forward P/S Multiple|Market Cap to Projected Revenue ALGN|GMED (NuVasive) - Forward P/S Multiple|TransMedics Corp (TMDX) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ATEC|Forward Price-to-Revenue Multiple Artivion, Inc. AORT|Forward P/S Multiple ENOV (enovis.com)|Forward P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Projected Revenue Ratio|BBNX: Price-to-Projected Revenue Ratio|IRMD (IRADIMED CORPORATION) - Forward Price-to-Revenue Multiple|Embecta Corp. - Forward Price to Sales|TNDM (Tandem Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AxoGen Inc AXGN|Price-to-Projected Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Projected Price to Revenue|Forward P/S Multiple BVS (bioventus.com)|Forward P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Forward P/S Multiple|Market Cap to Expected Sales Ratio Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Ophthalmic)|Price-to-Projected Revenue Ratio clearpointneuro.com|Forward Price-to-Revenue Multiple Stereotaxis, Inc. (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical - Price to Expected Revenue Ratio|VANI (Vivani Medical Inc) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue XTNT|NMTC (n1mtc.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Medical MODD|Price-to-Projected Revenue Ratio myomo.com (MYO)|Price-to-Projected Revenue Ratio COCH (envoymedical.com)|Price-to-Projected Revenue Ratio Vivos Therapeutics Inc VVOS|enVVeno Medical Corp. - Price-to-Projected Revenue Ratio|SINT: Forward Price-to-Revenue Multiple|TNON (Tenon Medical, Inc.) - Market Cap to Projected Revenue|Lifeward Ltd. (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility|Bone Biologics Corp. (BBLG) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Forward Price to Sales|Forward P/S Multiple DYNT (dynatronics.com)|Forward Price to Sales FNA|INVO Bioscience - Forward P/S Multiple